Non-significant efficacy of icotinib plus pleurodesis in epidermal growth factor receptor positive mutant lung cancer patients after malignant pleural effusion drainage compared to icotinib alone

BACKGROUND: To investigate the efficacy and safety of icotinib plus pleurodesis or icotinib alone in epidermal growth factor receptor (EGFR) positive mutant lung cancer patients after malignant pleural effusion (MPE) drainage. METHODS: In this retrospective study from initially reviewed case reports...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Thorac Dis
Autors principals: Xu, Yunhua, Fang, Wangsheng, Cheng, Bingye, Chen, Shanshan, Gu, Linping, Zhu, Li, Pan, Yan, Zhou, Zhen
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7330332/
https://ncbi.nlm.nih.gov/pubmed/32642157
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2020.03.49
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars